Zhejiang Chimin Pharm Co Ltd (603222) — Capital Reinvestment Ratio

Latest as of September 2025: 3.62x

Zhejiang Chimin Pharm Co Ltd (603222) has a Capital Reinvestment Ratio of 3.62x as of September 2025, meaning it reinvests 4% of its operating cash flow (CN¥3.84 Million) in capital expenditures (CN¥13.91 Million). See 603222 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

3.62x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥3.84 Million
CNY

Capital Expenditures

CN¥13.91 Million
CNY

Data as of

Sep 2025
Most recent filing

Zhejiang Chimin Pharm Co Ltd Capital Reinvestment Ratio (2011–2024)

This chart tracks Zhejiang Chimin Pharm Co Ltd's Capital Reinvestment Ratio across 14 annual periods.

Annual Capital Reinvestment Ratio for Zhejiang Chimin Pharm Co Ltd (2011–2024)

Year-by-year Capital Reinvestment Ratio for Zhejiang Chimin Pharm Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see 603222 market cap overview.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 1.67x CN¥72.99 Million CN¥122.01 Million ▲ +57.1%
2023 1.06x CN¥140.20 Million CN¥149.22 Million ▲ +11.1%
2022 0.96x CN¥204.65 Million CN¥196.11 Million ▼ -6.5%
2021 1.03x CN¥289.49 Million CN¥296.74 Million ▲ +1.6%
2020 1.01x CN¥166.29 Million CN¥167.76 Million ▲ +14.9%
2019 0.88x CN¥152.77 Million CN¥134.16 Million ▼ -58.3%
2018 2.10x CN¥123.99 Million CN¥260.85 Million ▼ -58.2%
2017 5.03x CN¥66.49 Million CN¥334.74 Million ▲ +271.8%
2016 1.35x CN¥72.12 Million CN¥97.64 Million ▲ +11.9%
2015 1.21x CN¥87.46 Million CN¥105.88 Million ▲ +143.4%
2014 0.50x CN¥77.36 Million CN¥38.47 Million ▲ +73.0%
2013 0.29x CN¥108.19 Million CN¥31.10 Million ▲ +52.1%
2012 0.19x CN¥169.88 Million CN¥32.11 Million ▼ -76.2%
2011 0.79x CN¥32.90 Million CN¥26.13 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow